Total Payments
$173,636
2024 Payments
$5,485
Companies
20
Transactions
167
Medicare Patients
583
Medicare Billing
$100,122
Payment Breakdown by Category
Consulting$133,551 (76.9%)
Travel$24,471 (14.1%)
Research$5,658 (3.3%)
Food & Beverage$5,601 (3.2%)
Other$4,300 (2.5%)
Gifts$55.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $133,551 | 49 | 76.9% |
| Travel and Lodging | $24,471 | 35 | 14.1% |
| Unspecified | $5,658 | 2 | 3.3% |
| Food and Beverage | $5,601 | 78 | 3.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,300 | 1 | 1.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,000 | 1 | 1.2% |
| Gift | $55.00 | 1 | 0.0% |
Payments by Type
General
$167,979
165 transactions
Research
$5,658
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $64,490 | 48 | $0 (2024) |
| Kite Pharma, Inc. | $21,987 | 26 | $0 (2023) |
| Novartis Pharma AG | $21,420 | 12 | $0 (2024) |
| Incyte Corporation | $18,911 | 16 | $0 (2021) |
| Gilead Sciences, Inc. | $11,990 | 15 | $0 (2018) |
| Celgene Corporation | $10,254 | 3 | $0 (2021) |
| National Marrow Donor Program | $5,389 | 25 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $4,535 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $2,858 | 4 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $2,700 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,485 | 14 | AstraZeneca Pharmaceuticals LP ($2,160) |
| 2023 | $12,171 | 26 | Kite Pharma, Inc. ($6,302) |
| 2022 | $15,466 | 28 | Kite Pharma, Inc. ($9,406) |
| 2021 | $19,109 | 6 | Celgene Corporation ($8,100) |
| 2020 | $6,125 | 3 | Incyte Corporation ($3,075) |
| 2019 | $55,851 | 33 | Novartis Pharmaceuticals Corporation ($32,807) |
| 2018 | $36,388 | 41 | Novartis Pharmaceuticals Corporation ($15,004) |
| 2017 | $23,041 | 16 | Novartis Pharmaceuticals Corporation ($14,172) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Cardinal Health 110 LLC | — | Consulting Fee | Cash or cash equivalent | $387.50 | General |
| 12/15/2024 | National Marrow Donor Program | — | Gift | In-kind items and services | $55.00 | General |
| 10/18/2024 | McKesson Sourcing Services, Inc. | — | Food and Beverage | Cash or cash equivalent | $34.77 | General |
| 07/24/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 06/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $413.33 | General |
| 04/20/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $81.59 | General |
| Category: Oncology | ||||||
| 03/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $160.26 | General |
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,000.00 | General |
| 02/23/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: Oncology | ||||||
| 02/23/2024 | McKesson Sourcing Services, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.90 | General |
| 02/22/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $131.93 | General |
| Category: Oncology | ||||||
| 01/15/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Novartis Pharma AG | KYMRIAH (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Novartis Pharma AG | KYMRIAH (Biological) | Travel and Lodging | In-kind items and services | $10.98 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | KYMRIAH (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Oncology | ||||||
| 12/10/2023 | Novartis Pharma AG | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $123.51 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: CELLT | ||||||
| 10/04/2023 | National Marrow Donor Program | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 10/01/2023 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $57.00 | General |
| 09/29/2023 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 07/06/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,076.00 | General |
| 06/30/2023 | National Marrow Donor Program | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 06/21/2023 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 06/21/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $97.84 | General |
| Category: Oncology | ||||||
| 05/19/2023 | Kite Pharma, Inc. | Tecartus (Drug) | Travel and Lodging | In-kind items and services | $54.00 | General |
| Category: CELLT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $5,658 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 116 | 204 | $39,991 | $16,643 |
| 2022 | 3 | 145 | 310 | $54,608 | $27,563 |
| 2021 | 3 | 153 | 353 | $64,224 | $33,923 |
| 2020 | 3 | 169 | 308 | $57,827 | $21,993 |
Total Patients
583
Total Services
1,175
Medicare Billing
$100,122
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 85 | 142 | $23,383 | $9,781 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 31 | 62 | $16,608 | $6,861 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 112 | $24,775 | $12,619 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 88 | 155 | $21,835 | $11,291 | 51.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 43 | $7,998 | $3,653 | 45.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 53 | 156 | $34,570 | $18,398 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 78 | 148 | $20,720 | $11,250 | 54.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 49 | $8,934 | $4,276 | 47.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 47 | 133 | $29,380 | $11,685 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 67 | 108 | $15,120 | $6,292 | 41.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 23 | $5,995 | $1,808 | 30.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 21 | 28 | $3,444 | $1,249 | 36.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 16 | $3,888 | $959.43 | 24.7% |
About Dr. David Porter, MD
Dr. David Porter, MD is a Hematology & Oncology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780627075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Porter, MD has received a total of $173,636 in payments from pharmaceutical and medical device companies, with $5,485 received in 2024. These payments were reported across 167 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($133,551).
As a Medicare-enrolled provider, Porter has provided services to 583 Medicare beneficiaries, totaling 1,175 services with total Medicare billing of $100,122. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Philadelphia, PA
- Active Since 06/14/2006
- Last Updated 03/23/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780627075
Products in Payments
- KYMRIAH (Biological) $51,348
- KYM_KYMRIAH_ONCOLOGY (Biological) $19,286
- Yescarta (Drug) $8,420
- JAKAFI (Drug) $6,325
- Tecartus (Drug) $6,278
- Zydelig (Drug) $6,093
- VYXEOS (Drug) $2,415
- TASIGNA (Drug) $2,358
- REZUROCK (Drug) $2,187
- DEFITELIO (Drug) $2,120
- BB-2121 (Drug) $2,025
- KYMRIAH (Drug) $1,328
- Revlimid (Drug) $129.17
- KEYTRUDA (Biological) $105.30
- Epkinly (Drug) $81.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Philadelphia
Shayma Kazmi, Md, MD
Hematology & Oncology — Payments: $715,210
Hematology & Oncology $715,210
Charu Aggarwal, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $510,275
Hematology & Oncology $510,275
Dr. Catherine Lai, M.d., M.p.h, M.D., M.P.H
Hematology & Oncology — Payments: $249,951
Hematology & Oncology $249,951
Dr. Martin Edelman, M.d, M.D
Hematology & Oncology — Payments: $207,464
Hematology & Oncology $207,464
Keith Pratz, M.d, M.D
Hematology & Oncology — Payments: $175,955
Hematology & Oncology $175,955
Marcela Maus, Md, MD
Hematology & Oncology — Payments: $159,783
Hematology & Oncology $159,783